Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450

References

• BACK, D. J., TEA, J. F., KARBWANG, J. and COLBERT, J., 1988, In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines. British Journal Clinical Pharmacology, 26, 23–29.
   PubMed Web of Science ®Google Scholar
• BALDWIN, S. J., BLOOMER, J. C., SMITH, G. J., AYRTON, A. D., CLARKE, S. E., CHENER, Y. and HENERY R. J., 1995, Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica, 25, 261–270.
   Google Scholar
• BATTULA, N., SAGARA, J. and GELBOIN, H. V., 1987, Expression of P1-450 and P3-450 DNA coding sequences as enzymatically active cytochromes P-450 in mammalian cells. Proceedings of the National Academy of Sciences, USA, 84, 4073–4077.
   PubMed Web of Science ®Google Scholar
• BONNABRY, P., LEEMANN, T. and DAYER, P., 1996, Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam. European Journal of Clinical Pharmacology, 49, 305–308.
   PubMed Web of Science ®Google Scholar
• BOURRIE, M., MEUNIER, V., BERGER, Y. and FABRE, G., 1996, Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 277, 321–332.
   PubMed Web of Science ®Google Scholar
• CHANG, T. K., GONZALEZ, F. J. and WAxmAN, D. J., 1994, Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Archives of Biochemistry and Biophysics, 311, 437–442.
   PubMed Web of Science ®Google Scholar
• CHANG, T. K., WEBER, G. F., CRESPI, C. L. and WAxmAN, D. J., 1993, Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Research, 53, 5629–5637.
   PubMed Web of Science ®Google Scholar
• GELBOIN, H. V. 1993, Cytochrome P450 and monoclonal antibodies. Pharmacological Review, 45, 413–453
   PubMed Web of Science ®Google Scholar
• GELBOIN, H. V., KRAUSZ, K. W., GOLDFARB, I., BUTERS, J. T., YANG, S. K., GONZALEZ, F. J., KORZEKWA, K. R. and SHou, M., 1995. Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4. Biochemical Pharmacology, 50, 1841–1850.
   PubMed Web of Science ®Google Scholar
• GONZALEZ, F. J., AOYAMA, T. and GELBOIN, H. V., 1991a, Expression of mammalian cytochrome P450 using vaccinia virus. Methods Enzymology, 206, 85–92.
   PubMedGoogle Scholar
• GONZALEZ, F. J., KIMURA, S., TAMURA, S. and GELBOIN, H. V., 1991b, Expression of mammalian cytochrome P450 using baculovirus. Methods Enzymology, 206, 93–99.
   PubMedGoogle Scholar
• GONZALEZ, F. J. and KORZEKWA, K. R., 1995, Cytochromes P450 expression systems. Annual Review of Pharmacology and Toxicology, 35, 369–390.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., KIM, D. H. and IwAsAxi, M., 1991, Role of human cytochrome P-450 IIEI in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology, 4, 168–179.
   PubMed Web of Science ®Google Scholar
• HALPERT, J. R., GUENGERICH, F. P., BEND, J. R. and CORREIA, M. A. 1994, Selective inhibitors of cytochromes P450. Toxicology and Applied Pharmacology, 125, 163–175.
   PubMed Web of Science ®Google Scholar
• HASEGAWA, T., HARA, K., KENMOCHI, T. and HATA, S., 1994, /n vitro metabolism of dorzolamide, a novel potent carbonic anhydrase inhibitor, in rat liver microsomes .D rug Metabolism and Disposition, 22, 916–921.
   PubMedGoogle Scholar
• HEYN, H., WHrrE, R. B. and STEVENS, J. C., 1996, Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Drug Metabolism and Disposition, 24, 948–954.
   PubMed Web of Science ®Google Scholar
• JOHNSON, E. F., SCHWAB, G. E. and MULLER -EBERHARD, U., 1979, Multiple forms of cytochrome P-450: catalytic differences exhibited by two homogeneous forms of rabbit cytochrome P-450. Molecular Pharmacology, 15, 708–718.
   Google Scholar
• KHARASCH, E. D. and THUMMEL, K. E., 1993, Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology, 79, 795–807.
   PubMed Web of Science ®Google Scholar
• KUNZE, K. L. and TRAGER, W. F., 1993, Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chemical Research in Toxicology, 6, 649–656.
   PubMed Web of Science ®Google Scholar
• LAKSHMI, V. M., ZENSER, T. V. and DAVIS, B. B., 1997, Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine. Drug Metabolism and Disposition, 25, 481–488.
   PubMed Web of Science ®Google Scholar
• LANG, D. H., RETTIE, A. E. and BOCKER, R. H., 1997, Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chemical Research in Toxicology, 10, 1037–1044.
   PubMed Web of Science ®Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., RARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MIDDLETON, JR, E. and KANDASWANMI, C., 1993, The flavonoids. In J. B. Harborne (ed.), Advances in Research since 1986 (London: Chapman & Hall), pp. 619–652.
   Google Scholar
• MILLER, G. L., 1959, Protein determination for a large number of samples. Analytical Chemistry, 31, 964–969.
   Web of Science ®Google Scholar
• NEWTON, D. J., WANG, R. and Lu, A. Y., 1995, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, K. R., 1964, The carbon monoxide-binding pigment of lover microsomes. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• OTTON, S. V., INABA, T. and KALO W., 1984, Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs. Life Science, 34, 73–80.
   PubMed Web of Science ®Google Scholar
• RODRIGUES, A. D., 1999, Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between c DNA -expre s se d cytochrome s P450 and native human liver microsomes. Biochemical Pharmacology, 57, 465–480.
   PubMed Web of Science ®Google Scholar
• SAI, Y., YANG, T. J., KRAUSZ, K. W., GONZALEZ, F. J. and GELBOIN, H. V., 1999, An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver. Pharmacogentics, 9, 229–237.
   PubMedGoogle Scholar
• SANDERINK, G. J., BOURNIQUE, B., STEVENS, J., PETRY, M. and MARTINET, M., 1997, Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. Journal of Pharmacology and Experimental Therapeutics, 282, 1465–1472.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drug, carcinogens and toxic chemicals; studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SHOU, M., GROGAN, J., MANCEWICZ, J. A., KRAUSZ, K. W., GONZALEZ, F. J., GELBOIN, H. V. and KORZEKWA, K. R., 1994a, Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry, 33, 6450–6455.
   PubMed Web of Science ®Google Scholar
• SHOU, M., KORZEKWA, K. R., KRAUSZ, K. W., CRFSPI, C. L., GONZALEZ, F. J. and GELBOIN, H. V., 1994b, Regio- and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Cancer Letters, 83, 305–313.
   PubMed Web of Science ®Google Scholar
• SMITH, D. A. and J0NEs, B. C., 1992, Speculations on the substrate structure—activity relationship (SSAR) of cytochrome P450 enzymes. Biochemical Pharmacology, 44, 2089–2098.
   Google Scholar
• SPRACKLIN, D. K., THUMMEL, K. E. and KHARASCH, E. D., 1996, Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Drug Metabolism and Disposition, 24, 976–983.
   PubMed Web of Science ®Google Scholar
• STEVENS, J. C., WHITE, R. B., Hsu, S. H. and MARTINET, M., 1997, Human liver CYP2B6-catalyzed hydroxylation of RP 73401. Journal of Pharmacology and Experimental Therapeutics, 282, 1389–1395.
   PubMed Web of Science ®Google Scholar
• TYNDALE, R. F., KALOW, W. and INABA, T., 1991, Oxidation of reduced haloperidol to haloperidol: involvement of human P450I1D6 (sparteine/debrisoquine monooxygenase). British Journal of Clinical Pharmacology, 31, 655–660.
   PubMed Web of Science ®Google Scholar
• WARD, S. and BACK, D. J., 1993, Metabolism of gestodene in human liver cytosol and microsomes in vitro. Journal of Steroid Biochemistry and Molecular Biology, 46, 235–243.
   PubMedGoogle Scholar
• YAMAZAKI, H., INui, Y., YUN, C. H., GUENGERICH, F. P. and SHEVIADA, T., 1992, Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialltylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis, 13, 1789–1794.
   PubMed Web of Science ®Google Scholar
• YANG, T. J., KRAUSZ, K. W., Suou, M., YANG, S. K., BUTERS, J. Y., GONZALEZ, F. J. and GELBOIN H. V., 1998, Inhibitory monoclonal antibody to human cytochrome P450 2B6. Biochemical Pharmacology, 55, 1633–1640.
   Google Scholar
• YUN, C. H., SHIMADA, T. and GUENGERICH, F. P., 1992, Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene. Cancer Research, 52, 1868–1874.
   PubMed Web of Science ®Google Scholar
• WANG, P. P., BEAUNE, P., KAMINSKY, L. S., DANNAN, G. A., KADLUBAR, F. F., LARREY, D. and GUENGERICH, F. P., 1983, Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry, 22, 5375–5383.
   PubMed Web of Science ®Google Scholar